According to GuruFocus Insider Data, these are the largest CEO sales during the past week: Karopharm Therapeuticcs Inc, Methode Electronics Inc, Gilead Sciences Inc, and Nimble Storage Inc.
Karyopharm Therapeutics Inc. (KPTI, Financial): CEO Michael Kauffman sold 200,000 Shares
CEO of Karyopharm Therapeutics Inc. (KPTI, Financial) Michael Kauffman sold 200,000 shares on 07/02/2014 at an average price of $42.5. Karyopharm Therapeutics Inc. has a market cap of $1.28 billion; its shares were traded at around $42.99 with and P/S ratio of 2149.50.
Karyopharm Therapeutics Inc. announced their 2014 first quarter results with revenues of $171,000 and net loss of $13.7 million.
CEO Michael Kauffman sold 400,000 shares of KPTI stock in June and July. Director Deepika Pakianathan, SVP, FINANCE & ADMIN, TREAS Paul Brannelly, and VP, GEN COUNSEL & SECRETARY Christopher Brett Primiano bought 117,919 shares of KPTI stock in May.
Methode Electronics Inc (MEI, Financial): CEO Donald W Duda sold 154,024 Shares
CEO of Methode Electronics Inc (MEI, Financial) Donald W Duda sold 154,024 shares on 07/02/2014 at an average price of $37.36. Methode Electronics, Inc. was incorporated in 1946 as an Illinois corporation and reincorporated in Delaware in 1966. Methode Electronics Inc has a market cap of $1.46 billion; its shares were traded at around $38.53 with a P/E ratio of 15.40 and P/S ratio of 1.92. The dividend yield of Methode Electronics Inc stocks is 0.80%. Methode Electronics Inc had an annual average earnings growth of 25.10% over the past 5 years.
CEO Donald W Duda sold 154,024 shares of MEI stock on 07/02/2014 at the average price of 37.36. CFO Douglas A Koman sold 37,334 shares of MEI stock on 07/02/2014 at the average price of 37.34.Â
Gilead Sciences Inc (GILD, Financial): Chairman and CEO John C Martin sold 140,625 Shares
Chairman and CEO of Gilead Sciences Inc (GILD, Financial) John C Martin sold 140,625 shares on 07/01/2014 at an average price of $84.84. Gilead Sciences, Inc. was incorporated in Delaware on June 22, 1987. Gilead Sciences Inc has a market cap of $134.99 billion; its shares were traded at around $87.90 with a P/E ratio of 32.30 and P/S ratio of 10.89. Gilead Sciences Inc had an annual average earnings growth of 8.20% over the past 5 years.
Gilead Sciences Inc reported their 2014 first quarter results. The Company announced revenues of $5.0 billion and net income of $2.2 billion.
Chairman and CEO John C Martin sold 703,125 shares of GILD stock from March to July. EVP, CFO Robin L Washington sold 78,026 shares of GILD stock in February, May, and June. EVP, Corp & Med Affairs Gregg H Alton, Director Richard James Whitley¸ Director John Francis Cogan, EVP, R&D and CSO Norbert W Bischofberger, and EVP Commercial Ops Paul Rutherford Carter sold 149,728 shares of GILD stock in June and July.
Nimble Storage Inc (NMBL, Financial): CEO Suresh Vasudevan sold 129,400 Shares
CEO of Nimble Storage Inc (NMBL, Financial) Suresh Vasudevan sold 129,400 shares on 07/02/2014 at an average price of $30.61. Nimble Storage Inc has a market cap of $2.13 billion; its shares were traded at around $29.61 with and P/S ratio of 5.53.
Nimble Storage Inc announced revenues of $465 million and net loss of $19.6 million for their 2015 first fiscal quarter results.
CEO Suresh Vasudevan sold 129,400 shares of NMBL stock on 07/02/2014 at the average price of 30.61. CFO Anup V Singh sold 150,000 shares of NMBL stock on 07/01/2014 at the average price of 30.25. Chief Technology Officer Umesh Maheshwari, VP Marketing Daniel Leary¸ 10% Owner Peter Nieh, and 10% Owner Christopher J Schaepe sold 124,200 shares of NMBL stock in June and July.
For the complete list of stocks that bought by their CEOs, go to: Insider Buys.
- CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
- Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
- Double Buys: Companies that both Gurus and Insiders are buying
- Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.
